Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia

Research output: Contribution to journalArticle

Abstract

The patient with a reduced ejection fraction and nonsustained ventricular tachycardia represents a common management problem for the physician. This article reviews the supporting evidence for the therapeutic options available for these patients according to the etiology of the reduced ejection fraction. In postinfarction patients, electrophysiology-guided implantable cardioverter defibrillator therapy improves survival more than antiarrhythmic therapy. In patients with nonischemic cardiomyopathy, the best therapy is yet undetermined. Ongoing clinical trials will hopefully direct future therapy.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalCurrent Cardiology Reports
Volume3
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Ventricular Tachycardia
Therapeutics
Implantable Defibrillators
Electrophysiology
Cardiomyopathies
Clinical Trials
Physicians
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{525af7449c8d41b8a69145d83ec2293e,
title = "Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia",
abstract = "The patient with a reduced ejection fraction and nonsustained ventricular tachycardia represents a common management problem for the physician. This article reviews the supporting evidence for the therapeutic options available for these patients according to the etiology of the reduced ejection fraction. In postinfarction patients, electrophysiology-guided implantable cardioverter defibrillator therapy improves survival more than antiarrhythmic therapy. In patients with nonischemic cardiomyopathy, the best therapy is yet undetermined. Ongoing clinical trials will hopefully direct future therapy.",
author = "Palma, {Eugen C.}",
year = "2001",
doi = "10.1007/s11886-001-0026-9",
language = "English (US)",
volume = "3",
pages = "219--223",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia

AU - Palma, Eugen C.

PY - 2001

Y1 - 2001

N2 - The patient with a reduced ejection fraction and nonsustained ventricular tachycardia represents a common management problem for the physician. This article reviews the supporting evidence for the therapeutic options available for these patients according to the etiology of the reduced ejection fraction. In postinfarction patients, electrophysiology-guided implantable cardioverter defibrillator therapy improves survival more than antiarrhythmic therapy. In patients with nonischemic cardiomyopathy, the best therapy is yet undetermined. Ongoing clinical trials will hopefully direct future therapy.

AB - The patient with a reduced ejection fraction and nonsustained ventricular tachycardia represents a common management problem for the physician. This article reviews the supporting evidence for the therapeutic options available for these patients according to the etiology of the reduced ejection fraction. In postinfarction patients, electrophysiology-guided implantable cardioverter defibrillator therapy improves survival more than antiarrhythmic therapy. In patients with nonischemic cardiomyopathy, the best therapy is yet undetermined. Ongoing clinical trials will hopefully direct future therapy.

UR - http://www.scopus.com/inward/record.url?scp=0035348105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035348105&partnerID=8YFLogxK

U2 - 10.1007/s11886-001-0026-9

DO - 10.1007/s11886-001-0026-9

M3 - Article

VL - 3

SP - 219

EP - 223

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 3

ER -